Compare EQT Corporation Common Stock (EQT) vs GE HealthCare Technologies Inc. Common Stock (GEHC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
EQT Corporation Common Stock vs GE HealthCare Technologies Inc. Common Stock — how do they compare? EQT Corporation Common Stock trades at $52.49 (market cap $33.00B), while GE HealthCare Technologies Inc. Common Stock trades at $68.6 (market cap $30.93B). The key difference: EQT Corporation Common Stock and GE HealthCare Technologies Inc. Common Stock are close in size by market cap, and EQT Corporation Common Stock pays the higher dividend (1.25%). Which is the better fit depends on your goals.
| EQT | GEHC | |
|---|---|---|
Market Cap | $33.00B | $30.93B |
Volume | 5,231,083 | 5,033,451 |
Sector | Energy | Health |
52-Week High | $67.93 | $88.16 |
52-Week Low | $48.56 | $59.48 |
Typical Hold Time | 1 Days | — |
Enterprise Value | $38.54B | $39.39B |
Dividend Yield | 1.25% | 0.23% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EQT trades at $54.43, up 2.27% today, with a bullish technical outlook and strong analyst consensus. The stock benefits from robust profitability, with a net income margin of 28.61% and a P/E ratio of 12.63. Recent news highlights a dividend increase and positive natural gas market tailwinds, while institutional buying activity supports sentiment. Earnings have mostly beaten expectations, with Q3 2026 results pending.
The outlook for EQT is positive, driven by operational efficiency, favorable natural gas demand, and a strong balance sheet. Risks include commodity price volatility and execution of growth plans. With a consensus price target of $70.33 implying significant upside, the stock presents a compelling opportunity for investors seeking exposure to the energy sector.
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About EQT Corporation Common Stock
EQT produces and transports natural gas, with production and midstream operations in the Appalachian Basin. Its operations are concentrated in Pennsylvania, West Virginia, and Ohio.
Read more on EQT →About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →
